Testimonial Tuesday at TFS Healthscience!
Our final exhibit of the year kicks off today at home in the Nordics! Visit Booth 38 at OCT Nordics and see how TFS blends scientific rigor, global reach, operational agility, and local expertise to keep trials moving, no matter the challenge.
We're excited to be in Gothenburg for NLS Days, connecting with the brightest minds in the Nordic life sciences.
Growth is more than moving forward, it’s about lifting others with you along the way. At TFS, we celebrate journeys that turn experience into impact and passion into leadership. Read more about Cristina López Roso story: From global perspectives to local impact, hashtag#AtTFS we’re a community of dedicated individuals committed to advancing clinical research and transforming challenges into opportunities. Explore our opportunities: https://bit.ly/43VfXeH
On #WorldAtopicEczemaDay, we honor the strength of patients, families, and caregivers. Maciej shares how TFS is committed to advancing research that brings new options to those in need. Greater awareness means more than visibility. It means listening to patient voices, supporting families, and ensuring research delivers treatments that truly make a difference for those living with atopic eczema. Explore how our hashtag#dermatology team is driving progress for patients: https://lnkd.in/e69pWNP8
A new chapter begins at TFS. With CEO Markus Granlund at the helm, we're doubling down on what sets us apart—Nordic strength, global reach, and a bold vision for digital transformation. Read the full story: https://lnkd.in/e36q2YFY From expanding into key markets to embracing AI and elevating sponsor partnerships, Markus shares how TFS is evolving to meet the future—faster, smarter, and with purpose. Discover where we’re headed and why it matters to sponsors, sites, and patients alike. hashtag#FeatureFriday hashtag#ClinicalCRO hashtag#TogetherWeMakeADifference
#PrecisionMedicine is revolutionizing #neurology! In our latest blog, Sara Doan explores how personalized treatments offer hope for patients with Alzheimer’s, Parkinson’s, and more. Discover the possibilities here: https://lnkd.in/e-76zind #AtTFS, we’re proud to have supported over 140 neuroscience trials in 30+ countries. Our expertise spans from early phase to real-world studies, driving breakthroughs in precision medicine and redefining neurological care. Learn more about how, together, we can make a difference in the lives of patients worldwide: www.tfscro.com. #NeuroscienceCRO #TogetherWeMakeADifference #Alzheimers #Parkinsons #ClinicalResearch
The FDA has approved PTC Therapeutics, Inc.'s gene therapy for AADC deficiency, a groundbreaking treatment offering hope to patients and families impacted by this rare neurodegenerative disorder. Read now: https://lnkd.in/gdtWR535 As a leading hashtag#NeuroscienceCRO, TFS is proud to support advancements in rare neurodegenerative research and celebrate innovative therapies like Kebilidi that transform lives. Congratulations to all involved! #FDAApproval #SectorSpotlight #GeneTherapy #RareDisease
As a leading #NeuroscienceCRO, we are dedicated to driving progress in Parkinson’s research and celebrate advances in new treatments, like VYALEV™, that bring renewed hope to patients. Learn more: https://lnkd.in/enQDxZmq #AtTFS, we’re committed to research that brings both hope and practical solutions to those impacted by Parkinson’s and other neurodegenerative conditions. Having supported over 39,000 patients across more than 140 neuroscience trials, TFS proudly empowers our partners to lead innovations that enrich and transform lives, working together toward a future where breakthroughs like these make an even greater impact on patient care. #FDAApproval #SectorSpotlight #ParkinsonsDisease #ClinicalCRO
